ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NWBO Northwest Biotherapeutics Inc (QB)

0.561
-0.0465 (-7.65%)
Feb 21 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,752,583
Bid Price 0.5551
Ask Price 0.5698
News -
Day High 0.6122

Low
0.4001

52 Week Range

High
1.11

Day Low 0.561
Company Name Stock Ticker Symbol Market Type
Northwest Biotherapeutics Inc (QB) NWBO OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0465 -7.65% 0.561 16:59:00
Open Price Low Price High Price Close Price Prev Close
0.6075 0.561 0.6122 0.561 0.6075
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
665 1,752,583 $ 0.575891 $ 1,009,296 - 0.4001 - 1.11
Last Trade Time Type Quantity Stock Price Currency
15:59:49 3,521 $ 0.561 USD

Northwest Biotherapeutics Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
196.15M 1.10B 972.39M 1.68M -105.03M -0.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Northwest Biotherapeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NWBO Message Board. Create One! See More Posts on NWBO Message Board See More Message Board Posts

Historical NWBO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5540.61220.5450.57786371,252,9190.0071.26%
1 Month0.61990.650.530.57565081,885,524-0.0589-9.50%
3 Months0.7150.8980.530.65572171,718,918-0.154-21.54%
6 Months0.4751.110.40010.72793982,199,9840.08618.11%
1 Year0.6821.110.40010.66992831,873,838-0.121-17.74%
3 Years1.412.150.38620.90665052,111,844-0.849-60.21%
5 Years0.2412.540.0050.84925212,283,8930.32132.78%

Northwest Biotherapeutics (QB) Description

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA.

Your Recent History

Delayed Upgrade Clock